Skip to content

APHARGA: what changed

BE 0762.565.401NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€3,449
2024 · €6,324-€2,876
Equity
€16,478
2024 · €44,030-€27,551
Cash
€20,457
2024 · €46,163-€25,706
Balance sheet total
€23,536
2024 · €51,378-€27,842

Largest movements

2024 to 2025
Assets
  • Cash -€25,706

    down €25,706 (-55.7%), from €46,163 to €20,457

    mainly Contributions, distributions and other (-€31,000) and Tax, wage and social debts (-€419)

  • Deferred charges and accrued income -€1,826

    down €1,826 (-50.0%), from €3,653 to €1,826

Equity and liabilities
  • Profit (loss) carried forward -€27,551

    down €27,551 (-65.6%), from €42,030 to €14,478

Income statement
  • Gross operating margin -€4,152

    down €4,152 (-38.1%), from €10,900 to €6,748

  • Depreciation -€595

    no longer reported in 2025 (was €595)

  • Taxes -€429

    down €429 (-20.2%), from €2,119 to €1,690

  • Financial charges -€253

    down €253 (-15.3%), from €1,658 to €1,405

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €6,324
Gross operating margin -€4,152
Depreciation +€595
Other operating charges -€1
Financial charges +€253
Taxes +€429
Result 2025 €3,449
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€5,294
Investment €0
Financing -€31,000
Cash 2024 €46,163
Net result for the year +€3,449
Receivables within one year +€309
Deferred charges and accrued income +€1,826
Trade debts +€143
Tax, wage and social debts -€419
Other debts -€14
Contributions, distributions and other -€31,000
Cash 2025 €20,457
brings cash intakes cash out
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €51,378 €23,536 -€27,842 -54.2%
Current assets 29/58 €51,378 €23,536 -€27,842 -54.2%
Amounts receivable within one year 40/41 €1,562 €1,253 -€309 -19.8%
Trade receivables 40 €1,562 €1,253 -€309 -19.8%
Cash at bank and in hand 54/58 €46,163 €20,457 -€25,706 -55.7%
Deferred charges and accrued income 490/1 €3,653 €1,826 -€1,826 -50.0%
Total equity and liabilities 10/49 €51,378 €23,536 -€27,842 -54.2%
Equity 10/15 €44,030 €16,478 -€27,551 -62.6%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 €42,030 €14,478 -€27,551 -65.6%
Amounts payable 17/49 €7,348 €7,058 -€290 -4.0%
Amounts payable within one year 42/48 €7,348 €7,058 -€290 -4.0%
Trade debts 44 €469 €612 +€143 +30.4%
Suppliers 440/4 €469 €612 +€143 +30.4%
Taxes, remuneration and social security 45 €6,057 €5,638 -€419 -6.9%
Taxes 450/3 €6,057 €5,638 -€419 -6.9%
Other amounts payable 47/48 €823 €808 -€14 -1.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €595 - -€595
Other operating charges 640/8 €204 €204 +€1 +0.3%
Gross operating margin 9900 €10,900 €6,748 -€4,152 -38.1%
Operating profit (loss) 9901 €10,102 €6,544 -€3,558 -35.2%
Financial charges 65/66B €1,658 €1,405 -€253 -15.3%
Recurring financial charges 65 €1,658 €1,405 -€253 -15.3%
Profit (loss) for the period before taxes 9903 €8,443 €5,138 -€3,305 -39.1%
Income taxes 67/77 €2,119 €1,690 -€429 -20.2%
Profit (loss) for the period 9904 €6,324 €3,449 -€2,876 -45.5%
Profit (loss) for the period to be appropriated 9905 €6,324 €3,449 -€2,876 -45.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€27,839 to €35,679

Midpoint €31,106 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €16,478
Capitalised earnings €39,200 to €54,880
Indication €27,839 to €35,679

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€16,478
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€16,478

Capitalised earnings

net result for the year (9904)
2025
€3,449
2024
€6,324
2023
€6,690
2022
€16,841
2021
€15,466
Average result
€5,488
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€39,200 / €45,733 / €54,880

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.